Hani Gabra
Imperial College London
H-index: 76
Europe-United Kingdom
Top articles of Hani Gabra
Oncolytic Vaccinia Virus Carrying OPCML Tumor Suppressor is active in Epithelial Ovarian Cancer
Cancer Research
2024/3/22
Cancer therapeutic methods utilizing OPCML fragment
2024/1/2
1h-pyrazolo [3, 4-d] pyrimidine compounds useful for the treatment of platinum-resistant cancer
2023/3/2
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
Gynecologic oncology
2023/3/1
Hani Gabra
H-Index: 54
Yan Jia
H-Index: 5
ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian …
Annals of Surgical Oncology
2023
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian …
Annals of Surgical Oncology
2023/1
The genomic landscape of recurrent ovarian high grade serous carcinoma: the BriTROC-1 study
medRxiv
2022/10/25
rOPCML-Fc as a potential tumor suppressive therapeutic agent for ovarian cancer
European Journal of Cancer
2022/10/1
AXL inhibition enhances Type 1 interferon (IFN) response and potentiates chemo-immunotherapy
Cancer Research
2022/6/15
Hani Gabra
H-Index: 54
AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells
Cell Reports Medicine
2022/3/15
Trametinib versus standard of care in patients with recurrent\ud low-grade serous ovarian cancer (GOG 281/LOGS):\ud an international, randomised, open-label, multicentre,\ud …
2022/2/5
OA01. 07 a phase II study of the oral selective Axl inhibitor bemcentinib with pembrolizumab in patients with advanced NSCLC
Journal of Thoracic Oncology
2021/3/1
Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers
2021/2
Jane Antony
H-Index: 7
Hani Gabra
H-Index: 54
Targeting the receptor AXL by bemcentinib prevents SARS-CoV-2 infection
Topics in Antiviral Medicine
2021
P-OGC39 The smell of oesophageal adenocarcinoma: opportunities for tests and treatments
British Journal of Surgery
2021/12/1
Bemcentinib (oral AXL inhibitor) in combination with low-dose cytarabine is well tolerated and efficacious in older relapsed AML patients. updates from the ongoing phase II …
Blood
2021/11/23
Grerk Sutamtewagul
H-Index: 6
Hani Gabra
H-Index: 54
602 AXL targeting with bemcentinb restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through innate immune cell mediated expansion of TCF1+ CD8 T cells
2021/11/1
Effects of obesity and post-bariatric surgery weight loss on the vaginal microbiota
2021/10/16
A novel application of calcium electroporation to cutaneous manifestations of gynaecological cancer
Eur. J. Gynaecol. Oncol
2021/8/15
A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy/safety of farletuzumab in combination with carboplatin plus paclitaxel or carboplatin plus …
Journal of Neurodevelopmental Disorders
2022/12